Geode Capital Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.6M Buy
2,014,029
+211,470
+12% +$1.22M ﹤0.01% 2262
2025
Q1
$11.9M Buy
1,802,559
+20,515
+1% +$135K ﹤0.01% 2180
2024
Q4
$15.5M Buy
1,782,044
+1,535
+0.1% +$13.4K ﹤0.01% 2096
2024
Q3
$34.8M Buy
1,780,509
+41,535
+2% +$812K ﹤0.01% 1660
2024
Q2
$35.8M Buy
1,738,974
+31,700
+2% +$653K ﹤0.01% 1585
2024
Q1
$36.4M Buy
1,707,274
+51,265
+3% +$1.09M ﹤0.01% 1567
2023
Q4
$23.8M Buy
1,656,009
+78,053
+5% +$1.12M ﹤0.01% 1807
2023
Q3
$14.4M Buy
1,577,956
+249,840
+19% +$2.28M ﹤0.01% 2032
2023
Q2
$14.1M Buy
1,328,116
+41,576
+3% +$440K ﹤0.01% 2090
2023
Q1
$15.7M Buy
1,286,540
+57,110
+5% +$698K ﹤0.01% 1959
2022
Q4
$15.3M Buy
1,229,430
+39,675
+3% +$492K ﹤0.01% 1955
2022
Q3
$16.3M Sell
1,189,755
-14,555
-1% -$199K ﹤0.01% 1890
2022
Q2
$22.1M Buy
1,204,310
+96,533
+9% +$1.77M ﹤0.01% 1696
2022
Q1
$17.8M Sell
1,107,777
-96,049
-8% -$1.54M ﹤0.01% 1973
2021
Q4
$16.9M Buy
1,203,826
+100,066
+9% +$1.4M ﹤0.01% 2075
2021
Q3
$20.7M Sell
1,103,760
-46,397
-4% -$869K ﹤0.01% 1939
2021
Q2
$24M Buy
1,150,157
+62,700
+6% +$1.31M ﹤0.01% 1845
2021
Q1
$30.7M Buy
1,087,457
+91,966
+9% +$2.6M ﹤0.01% 1587
2020
Q4
$32.5M Buy
995,491
+160,911
+19% +$5.26M 0.01% 1404
2020
Q3
$25.6M Buy
834,580
+93,712
+13% +$2.87M 0.01% 1342
2020
Q2
$12.1M Buy
740,868
+159,884
+28% +$2.61M ﹤0.01% 1816
2020
Q1
$5.78M Buy
580,984
+60,842
+12% +$605K ﹤0.01% 2058
2019
Q4
$7.15M Buy
520,142
+21,110
+4% +$290K ﹤0.01% 2237
2019
Q3
$7.57M Buy
499,032
+57,702
+13% +$875K ﹤0.01% 2112
2019
Q2
$8.69M Buy
441,330
+67,546
+18% +$1.33M ﹤0.01% 2051
2019
Q1
$6.2M Buy
373,784
+19,774
+6% +$328K ﹤0.01% 2209
2018
Q4
$4.97M Buy
354,010
+43,205
+14% +$607K ﹤0.01% 2231
2018
Q3
$5.44M Buy
310,805
+35,794
+13% +$626K ﹤0.01% 2304
2018
Q2
$5.01M Buy
275,011
+41,680
+18% +$759K ﹤0.01% 2325
2018
Q1
$4.37M Buy
233,331
+66,417
+40% +$1.25M ﹤0.01% 2314
2017
Q4
$2.55M Buy
166,914
+3,255
+2% +$49.8K ﹤0.01% 2616
2017
Q3
$2.45M Buy
163,659
+90,740
+124% +$1.36M ﹤0.01% 2638
2017
Q2
$678K Buy
72,919
+23,237
+47% +$216K ﹤0.01% 3253
2017
Q1
$437K Buy
49,682
+426
+0.9% +$3.75K ﹤0.01% 3356
2016
Q4
$290K Buy
49,256
+284
+0.6% +$1.67K ﹤0.01% 3465
2016
Q3
$306K Buy
+48,972
New +$306K ﹤0.01% 3453